ICD-10 Coding for Stevens-Johnson Syndrome(H16.2, L51.1, L51.1B)
Comprehensive guide on coding and documenting Stevens-Johnson syndrome using ICD-10 codes, including L51.1 and related drug reaction codes.
Complete code families applicable to Stevens-Johnson Syndrome
Compare key differences between these codes to ensure accurate selection
| Code | Description | When to Use | Key Documentation |
|---|---|---|---|
| L51.1 | Stevens-Johnson syndrome | Use when SJS is diagnosed without TEN overlap and meets clinical criteria. |
|
| T36-T50.XX5A | Adverse effect of drugs, medicaments and biological substances | Use as first-listed code when SJS is drug-induced. |
|
Clinical Decision Support
Always review the patient's clinical documentation thoroughly. When in doubt, choose the more specific code and ensure documentation supports it.
Key Information
Essential facts and insights aboutStevens-Johnson Syndrome
Alternative codes to consider when ruling out similar conditions
Use when BSA detachment is between 10-30%.
Documentation & Coding Risks
Avoid these common issues when documenting Stevens-Johnson Syndrome.
Vague documentation of skin lesions
Impact
Clinical: May lead to misdiagnosis or incorrect treatment., Regulatory: Non-compliance with documentation standards., Financial: Potential for denied claims or reduced reimbursement.
Mitigation
Use specific descriptors for skin and mucosal involvement, Include drug causality when applicable
Using L51.1 without T code for drug etiology
Impact
Reimbursement: Incorrect sequencing can lead to reduced reimbursement., Compliance: Non-compliance with coding guidelines., Data Quality: Inaccurate data on drug-induced conditions.
Mitigation
Always query for drug causality and sequence T code first.
Drug causality documentation
Impact
Failure to document drug causality can lead to audit issues.
Mitigation
Ensure all drug-related information is clearly documented.